orbital disease
Conditions
Interventions
Group mPA:At the end of the operation, 4 ml of 1% ropivacaine will be used for peribulbar anesthesia via lacrimal caruncle approach
Group PCIA:At the end of the operation, the patient-controlled intravenous analgesia device is connected to the intravenous infusion channel and starts to operate. The analgesia time is 24 hours after
Sponsors
Zhongshan Ophthalmic Center, Sun Yat-sun University
Eligibility
Sex/Gender
All
Age
16 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 16 to 65 years; 2. ASA physical status I to III; 3. Patients sign the informed consent before including.
Exclusion criteria
Exclusion criteria: 1. Patient with severe liver and kidney dysfunction; 2. Patient with disorders of hemostasis; 3. Patient having infection in the puncture site; 4. Patient exiting impaired cognitive function; 5. Patient having gastropathy; 6. Patient with history of chronic pain; 7. Patient having history of anesthestics allergy, eg fentanyl, flurbiprofen axetil, ropivacaine,etc.; 8. Patient taking analgesic or sedative drugs for a long time; 9. Exiting anyother factors likely to influence the results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence of postoperative complication;NRS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| mRSS score;heart rate;SBP;rescue analgesia;time to off bed;QoR-40 score;demographics;clinical characteristics; | — |
Countries
China
Contacts
Public ContactYanling Zhu
Zhongshan Ophthalmic Center, Sun Yat-sun University
Outcome results
None listed